Search

» » » » Pfizer will combine its off-patent drug business with Mylan - CNBC

Pfizer will combine its off-patent drug business with Mylan - CNBC

Pfizer will combine its off-patent drug business with Mylan  CNBC

Pfizer, the world's largest drugmaker, plans to divest its off-patent drug business and combine it with generic-drug maker Mylan. Under the agreement, which is ...


Pfizer will combine its off-patent drug business with Mylan - CNBC
Read More


Bagikan Berita Ini

Related Posts :

0 Response to "Pfizer will combine its off-patent drug business with Mylan - CNBC"

Post a Comment

Subscribe to: Post Comments (Atom)
Powered by Blogger.